Join the club for FREE to access the whole archive and other member benefits.

Lewis Gruber

CEO, CSO and Co-Founder of SIWA Therapeutics

 He is also the named inventor on all of SIWA Therapeutics’ portfolio of more than 60 global patents.Prior to founding SIWA, Gruber served as interim CEO of ZelleRX, an early stage biotechnology company with a natural killer cell therapy that destroys cancer cells. From 2000 to 2006, Gruber was CEO and Co-Founder of Arryx, Inc., a Chicago biotechnology company that brought to market a breakthrough research tool that uses lasers to allow researchers to simultaneously manipulate hundreds of microscopic objects in three dimensions.

Visit website:


See also: Company SIWA Therapeutics - Biotechnology company producing therapy that targets and destroys senescent cells.

Lewis Gruber Blog Posts

Highlights of Ending Age-Related Diseases 2020

Highlights of Ending Age-Related Diseases 2020

Key points from 20 presentations from world-leading researchers

Lewis Gruber News

Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year


Nature Biotechnology reviews the state of play of senolytics

Nature Biotechnology - 12-Nov-2020

In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...


LEAF interviews Lewis Gruber about targeting cancer and senescent cells (LEAF) - 11-Feb-2020

Biomarker caused by glycolysis seen in all types of cancer - exciting possibilities